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Background: T cell-dependent B-cell responses decline with age, indicating declined cognate helper activity of
aged CD4 + T cells for B cells. However, the mechanisms remain unclear. T follicular helper (Tfh) cells, a novel T
helper subset, play an essential role in helping B cells differentiation into long-lived plasma cells in germinal center
(GC) or short-lived plasma cells. In the present study, we proposed that there might existe changes of proportion,
phenotype or cytokine production of blood Tfh cells in healthy elderly individuals compared with healthy young
individuals.
Results: The results showed that frequencies of aged blood CXCR5 + CD4 + Tfh cells increased compared with
young subjects. Both aged and young blood CXCR5 + CD4 + Tfh cells constitutively expressed CD45RO, CCR7 and
CD28, and few of these cells expressed CD69 or HLA-DR, which indicated that they were resting memory cells.
There was no significant difference of IL-21 frequency production by aged blood CXCR5 + CD4 + Tfh determined
by FACS compared with young individuals, however, aged PBMCs produced significantly higher levels of IL-21
evaluated by ELISA. Furthermore, there were no significant differences of percentages of IFN-γ, IL-4, IL-17 or IL-22
production by aged Tfh cells compared with their counterparts of young individuals respectively. However,
frequencies of IL-17+ cells within aged CD4 + CXCR5-T cells were markedly lower than in the young individuals.
Furthermore we observed different frequencies of IFN-γ, IL-17, IL-4 or IL-22 production by Tfh or by CD4 + CXCR5- cells
in aged and young subjects respectively.
Conclusions: Our data demonstrated that the frequencies of blood memory CXCR5 + CD4 + Tfh cells increased in the
elderly population. There were similar frequencies of Th characterized cytokine production such as IL-21, IFN-γ, IL-4,
IL-17 or IL-22 in aged and young Tfh cells. However, aged PBMCs produced a significantly higher amount of IL-21
compare to young subjects.
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The immune system undergoes significant changes with
aging, which likely partly contributes to increased sus-
ceptibility to infections, malignancies, inflammatory dis-
eases, and reduced response to vaccination of elderly
individuals [1,2]. Significant decline in immune function
during aging is termed immunosenescence [3], and
higher frequencies of inflammatory diseases of elderly
people indicate that aging could be regarded as a condi-
tion of dys-regulated inflammation [4].
Age-associated alterations in immune dysfunction are
found in both innate and adaptive immunity in humans.
For example, age-associated changes in NK cell phenotype
have been previously reported that can be responsible of
functional NK cell deficiency [5,6]. DCs from elderly indi-
viduals are compromised in response to microorganisms
but display increased reactivity to self-antigens associated
with chronic inflammation and autoimmunity [7-9]. Most
importantly, profound changes in T cell function and sub-
sets are observed in elder individuals [10,11].
Elderly population suffers increased morbidity and
mortality from infectious diseases, therefore, the elderly
are highly encouraged to receive vaccinations for these
infections such as influenza and pneumococcal pneumo-
nia. However, the efficacy of vaccination reduces with
aging [12-14]. The mechanisms of increased infections
and declined response to vaccination partially due to de-
clined humoral response which are mainly due to func-
tion defects in cognate helper function of CD4 + T cells
and B cells. Accumulating evidence demonstrated that
the genesis, numbers and function of B cell altered with
aging- [15-19]. Declined cognate helper activity of aged
CD4 + T cells for B cells in mice were observed [20-22].
However, this phenomenon and mechanisms are not
well understoodin human beings.
A distinct subset of CD4+ helper T (Th) cells, Tfh cell
(Tfh) specialize in providing cognate help to antigen-
specific B cells in germinal centers (GCs). Tfh cells play
a key role in the formation of GCs and differentiation of
GC B cells into plasma cells and memory B cells [23,24].
In GCs, Tfh cells express master regulator transcription
factor Bcl6 for their generation and surface marker
CXCR5 which facilitates Tfh cells homing to B cell folli-
cles [25,26]. IL-21 is an important effector cytokine
secreted by Tfh cells and directly regulates B cell prolif-
eration and class switching [27]. However, it is extremely
challenging to obtain lymph node samples from humans
to define the role of Tfh cells in normal or diseases con-
ditions. Therefore, one study published on immunity
evaluated the relationship of blood CXCR5 + CD4 + T
cells with Tfh cells, and demonstrated that human blood
CXCR5 + CD4 + T cells shared functional properties with
Tfh cells, and appeared to represent their circulating
memory compartment [28].Therefore, in this study we determined whether there
were alterations in aged Tfh cells by detecting blood
CXCR5 + CD4 + T cells which represented Tfh cells in
blood. And we observed CD69 and HLA-DR expression
on CXCR5 + CD4 + Tfh cells from young or aged indi-
viduals respectively. Furthermore, Th characterized cyto-
kine IL-21, IFN-γ, IL-4, IL-17 or IL-22 secreted by age
or young Tfh cells were determined and compared.
Results
Increased proportion of peripheral blood CXCR5 + CD4 +
Tfh cells from the elderly individuals
First, we wanted to demonstrate whether cell percent-
ages or numbers of CXCR5 + CD4 + Tfh cells changed in
the elderly or not. The results showed that there was no
significant difference of lymphocyte counts (Figure 1A),
frequencies or cell counts of CD4 + T cells (Figure 1B,
1C) between young and aged healthy individuals. Inter-
estingly, frequencies of CXCR5 +CD4 + Tfh cells (18.90 ±
1.004%) from elderly individuals were significantly higher
compared with those from young people (15.71 ± 0.608%),
and correlated with age. Furthermore, the percentages of
blood Tfh cells from young children were the lower than
elder individuals (Figure 1D and 1F). In addition, there
was no significant difference of cell counts of CXCR5 +
CD4 +Tfh cells between aged and young subjects
(Figure 1E). These results demonstrated that aged
blood CXCR5 + CD4 + Tfh cells proportion increased
compared with young subjects.
Memory phenotype CD45RO and CCR7, and co-stimulatory
CD28 expression of aged blood CXCR5 + CD4 + Tfh cells
We evaluated whether there were some kind of differences
in the memory phenotype of CXCR5 +CD4 + Tfh cells
from aged individuals compared with young individuals.
First, we determined the memory phenotype CD45RO
and CCR7 expression on CXCR5 + CD4 +Tfh cells using
FACS. Both aged and young CXCR5 + CD4 +Tfh cells
constitutively expressed CD45RO and CCR7 (Figure 2A
and 2B), and there was no significantly difference between
healthy aged and young individuals (Figure 3A and 3B). In
addition, higher percentages of CD4 +CD45RO+, CD3 +
CD4-CD45RO+, and CD4 + CXCR5-CD45RO +memory
T cells were observed in aged individuals (Figure 3A). In
contrast, frequencies of CCR7 positive cells among CD4+,
CD3 +CD4- and CD4 +CXCR5-T cells from aged individ-
uals decreased, and there was significant difference of per-
centages of CCR7 + CD3 +CD4-Tcells of elderly subjects
compared with young subjects (Figure 3B).
Meanwhile, we determined co-stimulatory molecule
CD28 expression on blood CXCR5 + CD4 + Tfh cells
using FACS. Percentages of CD28 positive cells among
CD4+, CD3 + CD4- and CD4 + CXCR5-T cells from eld-
erly individuals significantly decreased compared with
Figure 1 Increased proportion of blood CXCR5 + CD4 + Tfh cells of aged subjects. A. LYM counts: lymphocyte counts of peripheral blood
(109/L). B. Percentages of CD4 + T cells (CD3 + CD4+) in lymphocytes from young and aged groups determined by FACS. C. Cell numbers of
CD4 + T cells in peripheral blood (109/L). D. Frequencies of Tfh cells (CXCR5 + CD4+) in CD4 + T cells determined by FACS. E. The total cell counts
of Tfh cells (CXCR5 + CD4+) in peripheral blood (109/L). F. Correlation of percentages of CXCR5 + CD4 + Tfh cells with age. One open circle or
filled square represented one individual. Data were expressed with line at mean with SEM.
Figure 2 CD45RO, CCR7, and CD28 expression on CD4+CXCR5+
Tfh cells as well as CD4 + T, CD3 + CD4-T and CD4 + CXCR5-T
cells. CD45RO (A), CCR7 (B) and CD28 (C) expression on CD4 + T,
CD3 + CD4-T, CD4 + CXCR5 + Tfh as well as CD4 + CXCR5-T cells from
young and aged subjects. Blood lymphocytes were first gated, and
then CD4 + T (CD3 + CD4+), CD3 + CD4-T, CXCR5 + CD4 + Tfh and
CXCR5-CD4+ T cells were analyzed by expression of CD45RO, CCR7 or
CD28. Representative results were shown. Thin line: isotype (iso) control,
heavy line: young individual (young), filled area: elderly individual (aged).
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and 3C). However, there were no differences of fre-
quencies of CD28 expression between aged and young
CXCR5 + CD4 + Tfh cells. Taken together, these results
indicated that Tfh cells constitutively expressed CD45RO
and CCR7, and were peripheral memory T cells.
Both aged and young blood Tfh cells are in resting state
Next, early activation marker CD69 and late activation
marker HLA-DR expression on Tfh and other T subsets
from young and aged individuals were evaluated by
FACS. The results showed frequencies of CD69+ cells
among CXCR5 + CD4 + Tfh cells, as well as CD4 + T,
CD3 + CD4-T and CD4 + CXCR5-T cells from healthy
elderly individuals had no significant change compared
with their counterparts of healthy young individuals
(Figure 4A). In addition, there were different proportions
of CD69+ cells among CD4+ and CD3 + CD4-T cells
both from healthy young and aged subjects. Similar with
CD69 expression, few of CD4+ or CD3 + CD4-T cells
subsets expressed HLA-DR, and there were no signifi-
cant differences of HLA-DR expression on CXCR5 +
CD4 + Tfh cells as well as on CD4 + T, CD3 + CD4-T
and CD4 + CXCR5-T cells from young subjects and aged
individuals (Figure 4B). Above results demonstrated that
both aged and young blood CXCR5 + CD4 + Tfh cells
were in resting state.
Similar frequency of IL-21 produced by aged and young
blood CXCR5 + CD4 + Tfh cells
IL-21 is mainly produced by Tfh cells, and it is a very
important cytokine of Tfh to help B cells. Therefore, we
determined IL-21 production by CXCR5 + CD4 + Tfh or
Figure 3 Statistical analysis of CD45RO, CCR7 and CD28 expression on CD4 + CXCR5 + Tfh and other T subsets. Percentages of CD45RO +
(A) (young subjects: n = 12, aged subjects: n = 11), CCR7+ (B) (young subjects: n = 6, aged subjects: n = 6) and CD28 + (C) (young subjects: n = 7,
aged subjects: n = 9) among CD4 + T, CD3 + CD4-T, CD4 + CXCR5 + Tfh and CD4 + CXCR5-T cells were shown as in histograms. Y: young
individuals, A: aged individuals. *: p < 0.05, n.s: no significant difference. All data were expressed with line at mean with SEM.
Zhou et al. Immunity & Ageing 2014, 11:12 Page 4 of 10
http://www.immunityageing.com/content/11/1/12CD4 + CXCR5-T cells using intracellular cytokine stain-
ing. The results showed that both Tfh and CD4 +
CXCR5-T cells could produce IL-21 (Figure 5A), and
there was no significant difference of frequencies of IL-
21+ cells inCD4 + CXCR5 + Tfh as well as CD4 +
CXCR5-T cells from the elderly compared with young
individuals (Figure 5B). Meanwhile, PBMCs were pre-
pared from healthy aged and young individuals, and cul-
tured in the absence or presence of PMA and inomycin
for 3 days, and then the concentration of IL-21 was de-
termined by ELISA. As shown in Figure 5C, there were
very low levels of IL-21 without stimulation from bothFigure 4 CD69 and HLA-DR expression on young or aged CD4 + CXCR
(A) and HLA-DR (B) expression on CD4 + T, CD3 + CD4-T, CD4 + CXCR5 + T
in histograms. Thin line: isotype control (iso), heavy line: young individual (you
of CD69 + (C) (young subjects: n = 13, aged subjects: n = 11), and HLA-DR + (D
CD4-T, CD4 + CXCR5 + Tfh and CD4 + CXCR5-T cells were shown. Y: young in
expressed with line at mean with SEM.aged and young individuals. Compared with young sub-
jects, aged PBMCs stimulation with PMA and inomycin
produced significantly higher levels of IL-21. These re-
sults indicated that IL-21 production by aged PBMCs in-
creased significantly compared with young individuals.
Th1, Th2, Th17 and Th22 characterized cytokine
production within CD4 + CXCR5 + Tfh or CD4 + CXCR5-T
cells from healthy aged and young individuals
Finally, we evaluated Th1, Th2, Th17, and Th22 characte-
rized cytokines IFN-γ, IL-4, IL-17 or IL-22 production
within blood CD4 + CXCR5 +Tfh cells or CD4 + CXCR5-5 + Tfh cells, CD4 + T, CD3 + CD4-T and CD4 + CXCR5-T cells. CD69
fh and CD4 + CXCR5-T cells from representative results were shown as
ng), filled area: elderly individual (aged). Statistical results of percentages
) (young subjects: n = 10, aged subjects: n = 10) among CD4 + T, CD3 +
dividuals, A: aged individuals. n.s: no significant difference. All data were
Figure 5 Similar frequency of IL-21 produced by aged and young blood CXCR5 + CD4 + Tfh cells. A. Representative results of IL-21+ cells
produced by Tfh or CD4 + CXCR5-cells were shown. B. FACS data of percentages of IL-21+ cells in CD4 + CXCR5 + Tfh cells or CD4 + CXCR5- cells
from both aged and young individuals (young subjects: n = 23, aged subjects: n = 23) were shown. C. IL-21 concentration determined by ELISA
was shown. PBMCs were prepared and cultured with P + I (PMA and inomycin) or – (medium) for 3 days. Supernatants were collected and IL-21
was evaluated by ELISA. *: p < 0.05. All data were expressed with line at mean with SEM.
Figure 6 Comparison of IFN-γ+, IL-17+, IL-4 + or IL-22+ cells among aged and young CXCR5 + CD4 + Tfh. PBMCs were prepared,
stimulated with PMA and inomycin for 4–6 hours, and intracellular staining were done. FACS data were analyzed: lymphocytes were first gated
and then CD4 + CXCR5+ or CD4 + CXCR5- cells were gated and cytokines such as IFN-γ, IL-17, IL-4 and IL-22 were analyzed. Statistical data of
frequencies of IFN-γ + (A), IL-17 + (B), IL-4 + (C) and IL-22 + (D) among CD4 + CXCR5 + Tfh or CD4 + CXCR5- cells were shown. *: p < 0.05, n.s:
no significant difference. All data were expressed with line at mean with SEM.
Zhou et al. Immunity & Ageing 2014, 11:12 Page 5 of 10
http://www.immunityageing.com/content/11/1/12
Zhou et al. Immunity & Ageing 2014, 11:12 Page 6 of 10
http://www.immunityageing.com/content/11/1/12T cells from young and elderly subjects. The results
showed that there were no significant differences of per-
centages of IFN-γ+, IL-4+, or IL-22 + cells within aged
blood CD4 + CXCR5 + Tfh or CD4 + CXCR5-T cells com-
pared with their counterparts of young individuals re-
spectively (Figure 6A, 6C and 6D). However, frequencies
of IL-17 producing cells within aged CD4 +CXCR5-T cells
were markedly lower, and there was a slight tendency for
IL 17-producing cells to be lower in the elderly (p = 0.155)
(Figure 6B). Moreover, lower percentages of IFN-γ + or
IL-4 production by young blood CXCR5 +CD4 + Tfh
cells, and higher frequencies of IL-17 or IL-22 production
by blood young or aged CXCR5 +CD4 + Tfh cells were
observed compared with their counterparts within CD4 +
CXCR5-T cells, respectively. There was no significant dif-
ference of frequencies of IFN-γ or IL-4 producing cells
within aged CD4 + CXCR5-T cells and aged CXCR5 +
CD4+ Tfh cells (Figure 7).
Discussion
Tfh cells have been recently established as a novel Th sub-
set specialized for providing help to B cells in GCs to dif-
ferentiate into long-lived memory B and plasma cells
[23,24]. Age-related declines in humoral responses are
mainly due to defects in the cognate helper function of
CD4 + T cells and in the B cells from aged individuals
[15-19]. However, this phenomenon and the mechanisms
of declined cognate helper activity of aged CD4 + T cells
for B cells remain not well understood in human beings.Figure 7 Different frequencies of IFN-γ+, IL-17+, IL-4+ or IL-22+ cells
frequencies of IFN-γ + (A), IL-17 + (B), IL-4 + (C) and IL-22 + (D) among CD4
expressed with line at mean with SEM. Differences between two groups w
significant difference.In the present study, we determined whether there are al-
terations of Tfh cells in aging of human beings.
First, we determined peripheral blood CXCR5 + CD4 +
Tfh cells from healthy young and elderly individuals. It
is extremely challenging to determine GCs’ Tfh cells
through obtaining lymph node samples from healthy
humans routinely. As demonstrated by one study pub-
lished on immunity, human blood CXCR5 + CD4 + T
cells shared functional properties with Tfh cells and ap-
peared to represent their circulating memory compart-
ment [28]. Therefore, we defined blood CXCR5 + CD4 +T
cells as peripheral blood Tfh by FACS. The results
demonstrated that frequencies of aged CXCR5 + CD4
+ Tfh cells were higher than those of young Tfh cells,
and correlated with age (Figure 1). Consistent with our
results, aged mice have increased numbers of isolated
lymphoid follicles (ILFs), an increased T-lymphocyte
population within aged ILFs [29]. We observed that
there were no significant differences of percentages or
cell counts of CD4 + T cells. Different literatures re-
ported different data about change of CD4 + T number
and percentage in the elderly. Hirokawa et al. observed
an age-related increase in the number of CD4+ T cells
in the Japanese population [30]. Provinciali et al’s re-
sults showed the absolute number of total CD4+ T cells
was progressively reduced with increasing age in Ital-
ian population [31]. Lower cell counts not percentages
of CD4 + T cells in the elderly in Hongkong were ob-
served [32]. The different data might be due to race,among Tfh compared with CD4 + CXCR5- cells. Statistical data of
+ CXCR5 + Tfh or CD4 + CXCR5- cells were shown. All data were
ere assessed by paired t test for two-tails. *: p < 0.05, n.s: no
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population of CD4 + T cells [32,33].
Then, we evaluated and compared the memory pheno-
type CD45RO and CCR7and co-stimulatory molecule
CD28 expression on CXCR5 + CD4 + Tfh cells. The re-
sults showed that both aged and young blood CXCR5 +
CD4 + Tfh cells constitutively expressed CD45RO and
CCR7, and there was no difference between young and
aged subjects (Figures 2 and 3). As we know, both
CD45RO and CCR7 are expressed by central memory T
cells [34]. Consistent with previous reports [28,35-37],
blood CXCR5 + CD4 + Tfh cells co-expressing CD45RO
and CCR7 belong to memory T cells. In addition, similar
with other studies, we observed that aged memory CD4+
T cells accumulated increased [10,11,38]. Moreover, we
demonstrated that blood CXCR5 + CD4 + Tfh cells con-
stitutively expressed co-stimulatory molecule CD28
(Figures 2 and 3). CD28, a major co-stimulatory recep-
tor, was responsible for the optimal antigen-mediated
T-cell activation, proliferation and survival of T cells.
Previous reports demonstrated that CD28 was essential
for Tfh development [39]. Furthermore, decreased
CD28 expression on aged CD4 + T, CD3 + CD4-T or
CXCR5-CD4 + T cells was observed in this study. Con-
sistent with our results, the accumulation of CD28 (−)
T cells, particularly within the CD8 subset, is one of the
most prominent changes during in the age-associated
decline of immune function in humans [40]. Blood
CXCR5 + CD4 +Tfh cells constitutively expressed CD28,
which indicated that these cells could be fully activated
and play a key role in development and function of
CXCR5 + CD4 +Tfh cells from both aged and young
subjects.
IL-21 is the most potent cytokine known for driving B
cells differentiation into plasma cells in both mice and
humans, and is highly secreted by Tfh cells, although
not exclusively secreted by Tfh cells [27,41,42]. In this
study, we demonstrated aged PBMCs produced signifi-
cantly higher levels of IL-21compared with young sub-
jects (Figure 5). Consistent with our observation, there
has been recently reported that aged CD4 + T cells from
healthy elderly individuals secreted significantly higher
levels of IL-21 on priming with dendritic cells (DC)
under anti-CD3 plus anti-CD28 mAbs [43], and IL-21
was mainly produced by memory CD4 + T cells [44].
There were higher memory CD4 + T cells in aged sub-
jects, therefore there were higher levels of IL-21 pro-
duced by aged PBMCs. In contrast, there has been
reported that aged memory CD4 + T cells expressed
lower levels of IL-21 after stimulated with anti-CD3 plus
anti-CD28 evaluated by real time RT-PCR [45]. The dif-
ferent results might be due to different experimental
condition. IL-21 is a cytokine that has broad effects on
immune and non-immune cells, and more and moredata suggest this cytokine is critically involved in the ini-
tiation and/or progression of inflammatory reactions
where self-reactive immune cells or antibodies cause
damage in tissue [46]. Increased IL-21 production by
aged PBMCs may significantly impact immune functions
in elderly individuals, and contribute to aging associated
inflammatory condition or diseases.
Recently, there was one literature which reported that
human blood CXCR5 + CD4 + Tfh cells comprised three
subsets: Th1, Th2 and Th17 cells with different capacity
to help B cells. Th2 and Th17 cells within CXCR5+, but
not within CXCR5-, compartment efficiently induced
naïve B cells to produce Abs. In contrast, Th1 cells from
both CXCR5+ and CXCR5- compartments lacked the
capacity to help B cells [28]. Our results demonstrated
that there were no significant differences of percentages of
IFN-γ, or IL-4 production by aged blood CD4 +CXCR5 +
Tfh or CD4 + CXCR5-T cells compared with their coun-
terparts of young individuals (Figure 6). Previous studies
about age-associated change in IFN-γ or IL-4 production
by T cells were largely inconsistent [47]. The frequencies
of IL-17+ cells produced by aged CD4 + CXCR5-T cells
were markedly lower, and frequencies of IL-17 produc-
tion by aged Tfh cells didn’t decrease significantly com-
pared with young subjects (Figure 6B).Consistent with
our results, previous study demonstrated that purified
memory CD4 + T cells from aged people produced
lower levels of frequency of Th17 cells compared with
the young [48].Conclusions
In conclusion, in the present study we observed that fre-
quencies of aged blood CXCR5 + CD4 +Tfh cells in-
creased. Aged or young blood CXCR5 + CD4 +Tfh cells
constitutively expressed CD28, and were resting T mem-
ory cells. There were similar frequencies of Th character-
ized cytokine production such as IL-21, IFN-γ, IL-4, IL-17
or IL-22 by aged and young Tfh cells. However, aged
PBMCs produced significantly higher amount of IL-21.
Future studies should observe whether there are defects of
aged Tfh cells in helping B cells to produce Abs.Materials and methods
Ethics statement
This study was conducted in compliance with the Dec-
laration of Helsinki and applicable national laws and reg-
ulations, and was approved by the ethics committee of
Guangzhou Medical University (Guangzhou, China) and
the ethics committee of Guangdong General Hospital,
Guangdong Academy of Medical Sciences (Guangzhou,
China). And written informed consent was obtained
from all healthy aged and young donors or the parents
of young children who participated in this study.
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Healthy young (age range: 22–39 years old, average
age: 29.5, male: n = 25, female: n = 20) and elderly
(age range: 60–86 years old, averaged age: 71.0,
male: n = 19, female: n = 24,) volunteers were critic-
ally selected on the basis of clinical records and la-
boratory examinations from Guangdong General
Hospital. Healthy young children (age: 0.8-2.8 years
old, average age: 2.1 years old, 4 girls, 4 boys) were
recruited from Guangdong General Hospital. We
regarded subjects as being healthy if they had no
neoplastic or autoimmune diseases, EBV, HBV, HCV,
TB infections, or serious prior illnesses, were receiv-
ing on no medication other than anti-hypertensive
medication. Routine laboratory examinations of the
serum of these individuals were performed to exam-
ine the liver and kidney functions. We did not inves-
tigate whether the subjects had previous infection
with cytomegalovirus (CMV) (Prevalence of CMV in-
fection is 90-100% in developing countries) [49].Reagents
Anti-CD4 PerCP, anti-CD4 PerCP-cy5.5, anti-CD3
APC, anti-CXCR5-Alexafluor 488, anti-CD45RO PE,
anti-CCR7 PE, anti-CD28 PE, anti-CD69 PE, anti-
HLA-DR PE, anti-IL-21 PE, anti-IL-4 PE, anti-IFN-γ
APC and isotype-matched control mAbs were pur-
chased from BD PharMingen (San Diego, CA, USA).
Anti-IL-17 APC and ELISA for determining IL-21 was
purchased from eBioscience (San Diego, CA, USA).
Anti-IL-22 PE was purchased from R & D Systems
(Abingdon, UK). PMA, ionomycin (INO), saponin and
Brefeldin A were purchased from Sigma-Aldrich
(Fluka, Sigma, USA).Cell surface staining
Heparinized blood was collected, then 50 ul blood per
tube was added, and anti-CD4 PerCP, anti-CD3 APC,
anti-CXCR5-Alexafluor488, anti-CD45RO PE, anti-
CCR7 PE, anti-CD28 PE, anti-CD69 PE, anti-HLA-DR
PE, and isotype-matched control mAbs were added into
tube and mixed, incubated 15–20 minutes at room
temperature. Erythrocytes were lysed with ammonium
chloride (NH4Cl) for 5–8 minutes. Cells were washed,
re-suspended with staining buffer, and detected by FACS
Calibur (BD Biosciences, San Jose, CA). The data were
analyzed using FlowJo software (Tree Star, Ashland, OR,
USA). Leukocyte count and differential were determined
with a routine hematology analyzer (COULTER LH780,
Beckman Coulter Inc., USA). The absolute counts of each
lymphocyte subpopulation were calculated by multiplying
the relative size of the lymphocyte subpopulation and the
absolute lymphocyte count.PBMCs preparation
Peripheral blood mononuclear cells (PBMCs) were isolated
from heparinized blood of healthy donors using Ficoll-
Hypaque density gradient centrifugation, and washed twice
in Hank’s balanced salt solution. These cells were finally
adjusted to a final concentration of 2 × 106 /ml in
complete RPMI 1640 medium (GIBCO, Grand Island,
NY, USA) supplemented with 10% FCS (Sijiqing, China),
100 U/mL penicillin, 100 mg/mL streptomycin, 50 mM
2-mercaptoethanol, and 2 mM L-glutamine (all from
GIBCO).Intracellular cytokine staining
PBMCs were stimulated with PMA (20 ng/ml) and iono-
mycin (1ug/ml) for 4–6 hours at 37°C in a 5% CO2 hu-
midified atmosphere. At the end of first hour during the
incubation, brefeldin A (BFA, 10 μg/ml) was added into
the culture. The cells were collected, washed twice with
cold PBS, and cells surface staining ofanti-CD4 PerCP-
cy5.5, anti-CXCR5-Alexafluor 488 was added for 20-
30 min. Cells were washed with PBS, fixed with 4%
paraformaldehyde and re-suspended in permeabilization
buffer (PBS containing 0.1% saponin and 0.5% BSA).
After incubation at 4°C for 2 hours or overnight, intra-
cellular cytokine staining of Anti-IL-21 PE, Anti-IL-22
PE, Anti-IL-4 PE, Anti-IL-17 APC, anti-IFN-γ APC, and
isotype-matched control mAbs were added and incu-
bated at 4°C for 25–30 min. Cells were washed with
PBS, resuspended in cold staining buffer, and detected
by FACSCalibur (BD Biosciences, San Jose, CA). The
data were analyzed using FlowJo software (Tree Star,
Ashland, OR, USA).Cell culture and ELISA for IL-21
PBMCs were prepared, adjusted to a final concentration
of 2 × 106 /ml, stimulated with PMA and inomycin or
medium, and cultured for 3 days. Cell free culture super-
natants were harvested and IL-21 was quantified by
enzyme-linked immunosorbent assay (ELISA) according
to the manufacturer’s instruction. The sensitive of ELISA
kit was 31 pg/ml for IL-21.Statistical analysis
Comparison between two groups was assessed by Mann
Whitney test for two-tails (except Figure 7, performed by
paired t test for two tails). P value of < 0.05 was considered
to be statistically significant. Data were expressed with
mean with SEM in results. All statistical analyses were per-
formed using GraphPad Prism (version 5.0 Software Inc,
San Diego, CA, USA).
Competing interests
The authors declare that they have no competing interests.
Zhou et al. Immunity & Ageing 2014, 11:12 Page 9 of 10
http://www.immunityageing.com/content/11/1/12Authors’ contributions
Conceived and designed the experiments: ES MZ. Performed the
experiments: MZ RZ HG ZL FL. Analyzed the data: MZ TL YL. Contributed
reagents/materials/analysis tools: ES MZ XC FH. Wrote the paper: ES RZ. All
authors read and approved the final manuscript.
Acknowledgements
This work was supported by The Natural Science Foundation of Guangdong
province (No. S2011040003741, S2012040006672), The Science and
Technology Planned Project of Bureau of Education of Guangzhou (No.
10A159), Distinguished Young Talents in Higher Education of Guangdong
province (No. LYM10111), the Guangzhou city-level key disciplines and
specialties of Immunology (No. B127007), and Doctoral Fund of Ministry of
Education of China (No. 20124423120003), Science and Technology Planning
Project of Guangdong Province (2013). The funders had no role in study
design, data collection and analysis, decision to publish, or preparation of
the manuscript.
Author details
1Department of Pathology and Laboratory Medicine, Guangdong General
Hospital, Guangdong Academy of Medical Sciences, Guangzhou 510080,
China. 2Department of Pathogenic Biology and Immunology, Guangzhou
Hoffmann Institute of Immunology, School of Basic Sciences, Guangzhou
Medical University, Guangzhou 510182, China. 3Department of Obstetrics and
Gynecology, The Third Affiliated Hospital of Guangzhou Medical University,
Guangzhou 510150, China.
Received: 14 May 2014 Accepted: 18 August 2014
Published: 23 August 2014
References
1. McElhaney JE, Effros RB: Immunosenescence: what does it mean to health
outcomes in older adults? Curr Opin Immunol 2009, 21:418–424.
2. Weinberger B, Schirmer M, MatteucciGothe R, Siebert U, Fuchs D, Grubeck-
Loebenstein B: Recall responses to tetanus and diphtheria vaccination
are frequently insufficient in elderly persons. PLoS One 2013, 8:e82967.
3. Pawelec G, Solana R: Immunosenescence. Immunol Today 1997, 10:514–516.
4. Shaw AC, Goldstein DR, Montgomery RR: Age-dependent dysregulation of
innate immunity. Nat Rev Immunol 2013, 13:875–887.
5. Camous X, Pera A, Solana R, Larbi A: NK cells in healthy aging and
age-associated diseases. J Biomed Biotechnol 2012, 2012:195956.
6. Gayoso I, Sanchez-Correa B, Campos C, Alonso C, Pera A, Casado JG,
Morgado S, Tarazona R, Solana R: Immunosenescence of human natural
killer cells. J Innate Immun 2011, 3:337–343.
7. Agrawal A, Tay J, Ton S, Agrawal S, Gupta S: Increased reactivity of
dendritic cells from aged subjects to self-antigen, the human DNA.
J Immunol 2009, 182:1138–1145.
8. Panda A, Qian F, Mohanty S, van Duin D, Newman FK, Zhang L, Chen S, Towle
V, Belshe RB, Fikrig E, Allore HG, Montgomery RR, Shaw AC: Age-associated
decrease in TLR function in primary human dendritic cells predicts
influenza vaccine response. J Immunol 2010, 184:2518–2527.
9. Wong C, Goldstein DR: Impact of aging on antigen presentation cell
function of dendritic cells. Curr Opin Immunol 2013, 25:535–541.
10. Fülöp T, Larbi A, Pawelec G: Human T cell aging and the impact of
persistent viral infections. Front Immunol 2013, 4:271.
11. Haynes L, Maue AC: Effects of aging on T cell function. Curr Opin Immunol
2009, 21:414–417.
12. Krone CL, van de Groep K, Trzciński K, Sanders EA, Bogaert D:
Immunosenescence and pneumococcal disease: an imbalance in host-
pathogen interactions. Lancet Respir Med 2014, 2:141–153.
13. Eilers R, Krabbe PF, van Essen TG, Suijkerbuijk A, van Lier A, de Melker HE:
Assessment of vaccine candidates for persons aged 50 and older: a
review. BMC Geriatr 2013, 13:32. doi: 10.1186/1471-2318-13-32.
14. Goodwin K, Viboud C, Simonsen L: Antibody response to influenza
vaccination in the elderly: a quantitative review. Vaccine 2006, 24:1159–1169.
15. Kogut I, Scholz JL, Cancro MP, Cambier JC: B cell maintenance and
function in aging. Semin Immunol 2012, 24:342–349.
16. Ademokun A, Wu YC, Dunn-Walters D: The ageing B cell population:
composition and function. Biogerontology 2010, 11:125–137.
17. Frasca D, Blomberg BB: Aging affects human B cell responses. J Clin
Immunol 2011, 31:430–435.18. Buffa S, Bulati M, Pellicanò M, Dunn-Walters DK, Wu YC, Candore G, Vitello S,
Caruso C, Colonna-Romano G: B cell immunosenescence: different features
of naive and memory B cells in elderly. Biogerontology 2011, 12:473–483.
19. Frasca D, Diaz A, Romero M, Landin AM, Phillips M, Lechner SC, Ryan JG,
Blomberg BB: Intrinsic defects in B cell response to seasonal influenza
vaccination in elderly humans. Vaccine 2010, 28:8077–8084.
20. Eaton SM, Burns EM, Kusser K, Randall TD, Haynes L: Age-related defects in
CD4 T cell cognate helper function lead to reductions in humoral
responses. J Exp Med 2004, 200:1613–1622.
21. Haynes L, Eaton SM: The effect of age on the cognate function of CD4+ T
cells. Immunol Rev 2005, 205:220–228.
22. Lefebvre JS, Maue AC, Eaton SM, Lanthier PA, Tighe M, Haynes L: The aged
microenvironment contributes to the age-related functional defects of
CD4 T cells in mice. Aging Cell 2012, 11:732–740.
23. Tangye SG, Ma CS, Brink R, Deenick EK: The good, the bad and the ugly - TFH
cells in human health and disease. Nat Rev Immunol 2013, 13:412–426.
24. Crotty S: Follicular helper CD4 T cells (TFH). Annu Rev Immunol 2011,
29:621–663.
25. Nurieva RI, Chung Y, Martinez GJ, Yang XO, Tanaka S, Matskevitch TD, Wang
YH, Dong C: Bcl6 mediates the development of T follicular helper cells.
Science 2009, 325:1001–1005.
26. Johnston RJ, Poholek AC, DiToro D, Yusuf I, Eto D, Barnett B, Dent AL, Craft
J, Crotty S: Bcl6 and Blimp-1 are reciprocal and antagonistic regulators of
T follicular helper cell differentiation. Science 2009, 325:1006–10010.
27. Nurieva RI, Chung Y, Hwang D, Yang XO, Kang HS, Ma L, Wang YH,
Watowich SS, Jetten AM, Tian Q, Dong C: Generation of T follicular helper
cells is mediated by interleukin-21 but independent of T helper 1, 2, or
17 cell lineages. Immunity 2008, 29:138–149.
28. Morita R, Schmitt N, Bentebibel SE, Ranganathan R, Bourdery L, Zurawski G,
Foucat E, Dullaers M, Oh S, Sabzghabaei N, Lavecchio EM, Punaro M,
Pascual V, Banchereau J, Ueno H: Human blood CXCR5 (+) CD4 (+) T cells
are counterparts of T follicular cells and contain specific subsets that
differentially support antibody secretion. Immunity 2011, 34:108–121.
29. McDonald KG, Leach MR, Huang C, Wang C, Newberry RD: Aging
impacts isolated lymphoid follicle development and function. Immun
Ageing 2011, 8:1.
30. Hirokawa K, Utsuyama M, Hayashi Y, Kitagawa M, Makinodan T, Fulop T:
Slower immune system aging in women versus men in the Japanese
population. Immun Ageing 2013, 10:19.
31. Provinciali M, Moresi R, Donnini A, Lisa RM: Reference values for CD4+ and
CD8+ T lymphocytes with naïve or memory phenotype and their
association with mortality in the elderly. Gerontology 2009, 55(3):314–321.
32. Chng WJ, Tan GB, Kuperan P: Establishment of adult peripheral blood
lymphocyte subset reference range for an Asian population by single-
platform flow cytometry: influence of age, sex, and race and comparison
with other published studies. Clin Diagn Lab Immunol 2004, 11:168–173.
33. Wertheimer AM, Bennett MS, Park B, Uhrlaub JL, Martinez C, Pulko V,
Currier NL, Nikolich-Žugich D, Kaye J, Nikolich-Žugich J: Aging and
cytomegalovirus infection differentially and jointly affect distinct
circulating T cell subsets in humans. J Immunol 2014, 192:2143–2155.
34. Sallusto F, Geginat J, Lanzavecchia A: Central memory and effector
memory T cell subsets: function, generation, and maintenance. Annu Rev
Immunol 2004, 22:745–763.
35. Schaerli P, Willimann K, Lang AB, Lipp M, Loetscher P, Moser B: CXC
chemokine receptor 5 expression defines follicular homing T cells with B
cell helper function. J Exp Med 2000, 192:1553–1562.
36. Breitfeld D, Ohl L, Kremmer E, Ellwart J, Sallusto F, Lipp M, Förster R:
Follicular B helper T cells express CXC chemokine receptor 5, localize to
B cell follicles, and support immunoglobulin production. J Exp Med 2000,
192:1545–1552.
37. Kim CH, Rott LS, Clark-Lewis I, Campbell DJ, Wu L, Butcher EC: Subspecialization
of CXCR5+ T cells: B helper activity is focused in a germinal center-localized
subset of CXCR5+ T cells. J Exp Med 2001, 193:1373–1381.
38. Farber DL, Yudanin NA, Restifo NP: Human memory T cells: generation,
compartmentalization and homeostasis. Nat Rev Immunol 2014,
14:24–35.
39. Linterman MA, Vinuesa CG: Signals that influence T follicular helper cell
differentiation and function. Semin Immuno Pathol 2010, 32:183–196.
40. Weng NP, Akbar AN, Goronzy J: CD28 (−) T cells: their role in the
age-associated decline of immune function. Trends Immunol 2009,
30:306–312.
Zhou et al. Immunity & Ageing 2014, 11:12 Page 10 of 10
http://www.immunityageing.com/content/11/1/1241. Yi JS, Cox MA, Zajac AJ: Interleukin-21: a multifunctional regulator of
immunity to infections. Microbes Infect 2010, 12:1111–1119.
42. Liu SM, King C: IL-21-producing Th cells in immunity and autoimmunity.
J Immunol 2013, 191:3501–3506.
43. Agrawal A, Su H, Chen J, Osann K, Agrawal S, Gupta S: Increased IL-21
secretion by aged CD4 + T cells is associated with prolonged STAT-4
activation and CMV seropositivity. Aging (Albany NY) 2012, 4:648–659.
44. Onoda T, Rahman M, Nara H, Araki A, Makabe K, Tsumoto K, Kumagai I, Kudo T,
Ishii N, Tanaka N, Sugamura K, Hayasaka K, Asao H: Human CD4+ central and
effector memory T cells produce IL-21: effect on cytokine-driven prolifera-
tion of CD4+ T cell subsets. Int Immunol 2007, 19:1191–1199.
45. Yu M, Li G, Lee WW, Yuan M, Cui D, Weyand CM, Goronzy JJ: Signal
inhibition by the dual-specific phosphatase 4 impairs T cell-dependent
B-cell responses with age. Proc Natl Acad Sci U S A 2012, 109:E879–E888.
46. Sarra M, Franzè E, Pallone F, Monteleone G: Targeting interleukin-21 in
inflammatory diseases. Expert Opin Ther Targets 2011, 15:695–702.
47. Lee N, Shin MS, Kang I: T-cell biology in aging, with a focus on lung
disease. J Gerontol A Biol Sci Med Sci 2012, 67:254–263.
48. Lee JS, Lee WW, Kim SH, Kang Y, Lee N, Shin MS, Kang SW, Kang I:
Age-associated alteration in naive and memory Th17 cell response in
humans. Clin Immunol 2011, 140:84–91.
49. Fang FQ, Fan QS, Yang ZJ, Peng YB, Zhang L, Mao KZ, Zhang Y, Ji YH:
Incidence of cytomegalovirus infection in Shanghai, China. Clin Vaccine
Immunol 2009, 16:1700–1703.
doi:10.1186/1742-4933-11-12
Cite this article as: Zhou et al.: The effect of aging on the frequency,
phenotype and cytokine production of human blood CD4 + CXCR5 + T
follicular helper cells: comparison of aged and young subjects. Immunity
& Ageing 2014 11:12.Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
